Business growth

Novacyt, together with Queen Mary University of London, began clinical trials using an innovative stationary testing system. The aim of the study is to find out whether daily COVID-19 testing reduces the frequency of infection, morbidity and mortality among high-risk populations. The study will involve 2000 people in 50 nursing homes in London.